Jukyoung Lee

Affiliations: 
Kangwon National University, Chuncheon, South Korea 
 Hwajin Corp. 
Google:
"Jukyoung Lee"
Mean distance: (not calculated yet)
 
BETA: Related publications

Publications

You can help our author matching system! If you notice any publications incorrectly attributed to this author, please sign in and mark matches as correct or incorrect.

Lim S, Ku EJ, Lee SY, et al. (2020) Therapeutic efficacy and safety of initial triple combination of metformin, sitagliptin, and lobeglitazone in drug-naïve patients with type 2 diabetes: initial triple study. Bmj Open Diabetes Research & Care. 8
Choi JY, Gim MS, Lee JY. (2020) Predictability of temperaments and negative experiences on higher-order symptom-based subtypes of depression. Journal of Affective Disorders. 265: 18-25
Kang SR, Shin H, Lee J, et al. (2020) Effects of smartphone application education combined with hands-on practice in breast self-examination on junior nursing students in South Korea. Japan Journal of Nursing Science : Jjns. e12318
Yahng SA, Min GJ, Park SS, et al. (2020) Role of pre-transplant anti-thymocyte globulin in matched sibling donor- stem cell transplantation after reduced intensity conditioning for MDS. European Journal of Haematology
Ryu JH, Ko HJ, Shim JR, et al. (2020) Eosinophil to monocyte ratio is an excellent predictor of acute cellular rejection in pancreas transplant alone recipients. Clinical Transplantation
Hwang J, Song I, Lee K, et al. (2020) KRCA-0008 suppresses ALK-positive anaplastic large-cell lymphoma growth. Investigational New Drugs
Lee J, Purushothaman B, Song JM. (2020) Inkjet Bioprinting on Parchment Paper for Hit Identification from Small Molecule Libraries. Acs Omega. 5: 588-596
Lee JW, Kim N, Park B, et al. (2020) Blood pressure trajectory modeling in childhood: birth-cohort study. Clinical Hypertension. 26: 2
Jung JW, Kim JE, Kim E, et al. (2020) Amino acid transporters as tetraspanin TM4SF5 binding partners. Experimental & Molecular Medicine
Park HK, Yoon NG, Lee JE, et al. (2020) Unleashing the full potential of Hsp90 inhibitors as cancer therapeutics through simultaneous inactivation of Hsp90, Grp94, and TRAP1. Experimental & Molecular Medicine
See more...